Clinical trials
Phase 1 Metabolic Syndrome trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
48 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 5 |
| 2007 | 2 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 3 |
| 2012 | 4 |
| 2013 | 4 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 2 |
| 2019 | 1 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 31 |
| Unknown status | 7 |
| Recruiting | 3 |
| Terminated | 3 |
| Not yet recruiting | 2 |
| Withdrawn | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lund University | 4 |
| Yungjin Pharm. Co., Ltd. | 3 |
| Catholic University of the Sacred Heart | 2 |
| Philip Kern | 2 |
| University of Michigan | 2 |
| University of Wisconsin, Madison | 2 |
| Aphaia Pharma US LLC | 1 |
| Fukuoka University | 1 |
| Gary Van Guilder | 1 |
| Inversago Pharma Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Metabolic Syndrome | 48 |
| Obesity | 18 |
| Insulin Resistance | 6 |
| Hypertension | 5 |
| Diabetes Mellitus | 4 |
| Hyperlipidemias | 4 |
| Overweight | 4 |
| Prediabetic State | 4 |
| Diabetes Mellitus, Type 2 | 3 |
| Hyperglycemia | 3 |
Trials
Showing 1 to 25 of 48. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.